The PI3K/AKT and TGFβ signaling pathways, at least one of which is altered in over 70% of cervical cancers, are very promising in that targeted therapies may be broadly applicable due to their high prevalence [18]. The gene discussed is PIK3CA; the disease is cervical carcinoma.